Connect
← Return to My experience in High Risk MGUS & Non High Risk SMM trial
Discussion
My experience in High Risk MGUS & Non High Risk SMM trial
Blood Cancers & Disorders | Last Active: 1 day ago | Replies (9)Comment receiving replies
@hsminc
Linvoseltamab is a FDA approved immunotherapy drug used to treat relapsed or refractory multiple myeloma. Approved for adults who have already received at least four prior therapy lines. Clinical trial is to see if it can delay progression.
I believe I am intermediate SMM because my kappa lambda free light chain ratio is greater than 20. My plasma cell percentage is 10-15 % and my FISH panel showed gain of 1Q and monosomy 13 which apparently puts me on a faster track to progression.
I am cautiously optomistic.
Replies to "@hsminc Linvoseltamab is a FDA approved immunotherapy drug used to treat relapsed or refractory multiple myeloma...."
Connect
@righty01
Congratulations on being a participant in the trial.
I wish you well with the trial. I am finished with the treatment as of June 2. Numbers are way down. I have been designated CR and am not yet MRD negative. My bone marrow biopsy showed some remaining cellular presence. Linvoseltamab has a very long half life and I am hoping the biopsy in November will show no cells.